Mark K Oki - Net Worth and Insider Trading
Mark K Oki Net Worth
The estimated net worth of Mark K Oki is at least $27,867 dollars as of 2024-04-23. Mark K Oki is the CFO of Aytu BioPharma Inc and owns about 9,500 shares of Aytu BioPharma Inc (AYTU) stock worth over $26,693. Mark K Oki is also the CFO & CAO of VIVUS Inc and owns about 10,000 shares of VIVUS Inc (VVUSQ) stock worth over $1,174. Details can be seen in Mark K Oki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark K Oki has not made any transactions after 2022-11-18 and currently still holds the listed stock(s).
Transaction Summary of Mark K Oki
Mark K Oki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark K Oki owns 3 companies in total, including VIVUS Inc (VVUSQ) , Alexza Pharmaceuticals Inc (ALXA) , and Aytu BioPharma Inc (AYTU) .
Click here to see the complete history of Mark K Oki’s form 4 insider trades.
Insider Ownership Summary of Mark K Oki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VVUSQ | VIVUS Inc | 2020-01-29 | Chief Financial Officer & CAO |
| ALXA | Alexza Pharmaceuticals Inc | 2015-10-16 | Former SVP & CFO & Secretary |
| AYTU | Aytu BioPharma Inc | 2023-08-11 | Chief Financial Officer |
Mark K Oki Latest Holdings Summary
Mark K Oki currently owns a total of 2 stocks. Among these stocks, Mark K Oki owns 9,500 shares of Aytu BioPharma Inc (AYTU) as of November 18, 2022, with a value of $26,693 and a weighting of 95.79%. Mark K Oki also owns 10,000 shares of VIVUS Inc (VVUSQ) as of November 6, 2018, with a value of $1,174 and a weighting of 4.21%.
Latest Holdings of Mark K Oki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AYTU | Aytu BioPharma Inc | 2022-11-18 | 9,500 | 2.81 | 26,693 |
| VVUSQ | VIVUS Inc | 2018-11-06 | 10,000 | 0.12 | 1,174 |
Holding Weightings of Mark K Oki
Mark K Oki Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark K Oki has made a total of 1 transactions in Aytu BioPharma Inc (AYTU) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aytu BioPharma Inc is the acquisition of 4,500 shares on November 18, 2022, which cost Mark K Oki around $20,700.
According to the SEC Form 4 filings, Mark K Oki has made a total of 0 transactions in VIVUS Inc (VVUSQ) over the past 5 years. The most-recent trade in VIVUS Inc is the acquisition of 10,000 shares on November 6, 2018, which cost Mark K Oki around $40,700.
Insider Trading History of Mark K Oki
- 1
Mark K Oki Trading Performance
GuruFocus tracks the stock performance after each of Mark K Oki's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark K Oki is -2.11%. GuruFocus also compares Mark K Oki's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark K Oki within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark K Oki's insider trading performs compared to the benchmark.
Performance of Mark K Oki
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -22.1 | -2.11 | -29.21 | -37.11 | -69.24 | |
| Relative Return to S&P 500(%) | -19.6 | -3.11 | -35.36 | -49.86 | -82.08 |
Mark K Oki Ownership Network
Ownership Network List of Mark K Oki
Ownership Network Relation of Mark K Oki
Mark K Oki Owned Company Details
What does VIVUS Inc do?
Who are the key executives at VIVUS Inc?
Mark K Oki is the Chief Financial Officer & CAO of VIVUS Inc. Other key executives at VIVUS Inc include director & Chief Executive Officer John P. Amos , Chief Medical Officer Santosh T Varghese , and SVP & Business Development & GC John L Slebir .
VIVUS Inc (VVUSQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of VIVUS Inc (VVUSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VIVUS Inc (VVUSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
VIVUS Inc (VVUSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
VIVUS Inc Insider Transactions
Mark K Oki Mailing Address
Above is the net worth, insider trading, and ownership report for Mark K Oki. You might contact Mark K Oki via mailing address: C/o Alexza Pharmaceuticals Inc, 2091 Stierlin Court, Mountain View Ca 94043.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
